Pseudomalabsorption of Levothyroxine

Kenneth B. Ain, Samuel Refetoff, Henry G. Fein, Bruce D. Weintraub

Research output: Contribution to journalArticle

Abstract

Objective.—The issue of patient compliance with pharmacological therapy vs malabsorption of medication was explored in the context of persistent hypothyroidism despite the administration of large doses of levothyroxine sodium. Design.—Retrospective case series. Setting.—Referred care in two large tertiary care centers. Patients.—Four patients, seen within two decades, with clinical and biochemical hypothyroidism while receiving levothyroxine, were evaluated for selective malabsorption of this hormone. Interventions.—Studies included serial measurements of thyroid hormone levels after a loading dose of levothyroxine or liothyronine sodium or evaluation with a double-labeled thyroxine tracer technique. Results were compared with studies of levothyroxine malabsorption in the medical literature. Results.—All patients were ultimately found to have normal (82% to 100%) absorption of oral levothyroxine. There was no evidence that malabsorption of levothyroxine can occur as an isolated abnormality. Conclusions.—Some patients exhibit a factitious disorder suggesting malabsorption of levothyroxine. When treating hypothyroidism, psychiatric issues may result in noncompliance with levothyroxine therapy.

Original languageEnglish (US)
Pages (from-to)2118-2120
Number of pages3
JournalJournal of the American Medical Association
Volume266
Issue number15
DOIs
StatePublished - Oct 16 1991
Externally publishedYes

Fingerprint

Thyroxine
Hypothyroidism
Factitious Disorders
Triiodothyronine
Patient Compliance
Thyroid Hormones
Tertiary Care Centers
Psychiatry
Hormones
Pharmacology
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ain, K. B., Refetoff, S., Fein, H. G., & Weintraub, B. D. (1991). Pseudomalabsorption of Levothyroxine. Journal of the American Medical Association, 266(15), 2118-2120. https://doi.org/10.1001/jama.1991.03470150090036

Pseudomalabsorption of Levothyroxine. / Ain, Kenneth B.; Refetoff, Samuel; Fein, Henry G.; Weintraub, Bruce D.

In: Journal of the American Medical Association, Vol. 266, No. 15, 16.10.1991, p. 2118-2120.

Research output: Contribution to journalArticle

Ain, KB, Refetoff, S, Fein, HG & Weintraub, BD 1991, 'Pseudomalabsorption of Levothyroxine', Journal of the American Medical Association, vol. 266, no. 15, pp. 2118-2120. https://doi.org/10.1001/jama.1991.03470150090036
Ain, Kenneth B. ; Refetoff, Samuel ; Fein, Henry G. ; Weintraub, Bruce D. / Pseudomalabsorption of Levothyroxine. In: Journal of the American Medical Association. 1991 ; Vol. 266, No. 15. pp. 2118-2120.
@article{7815b33d7b764217886f0aa76b0c1618,
title = "Pseudomalabsorption of Levothyroxine",
abstract = "Objective.—The issue of patient compliance with pharmacological therapy vs malabsorption of medication was explored in the context of persistent hypothyroidism despite the administration of large doses of levothyroxine sodium. Design.—Retrospective case series. Setting.—Referred care in two large tertiary care centers. Patients.—Four patients, seen within two decades, with clinical and biochemical hypothyroidism while receiving levothyroxine, were evaluated for selective malabsorption of this hormone. Interventions.—Studies included serial measurements of thyroid hormone levels after a loading dose of levothyroxine or liothyronine sodium or evaluation with a double-labeled thyroxine tracer technique. Results were compared with studies of levothyroxine malabsorption in the medical literature. Results.—All patients were ultimately found to have normal (82{\%} to 100{\%}) absorption of oral levothyroxine. There was no evidence that malabsorption of levothyroxine can occur as an isolated abnormality. Conclusions.—Some patients exhibit a factitious disorder suggesting malabsorption of levothyroxine. When treating hypothyroidism, psychiatric issues may result in noncompliance with levothyroxine therapy.",
author = "Ain, {Kenneth B.} and Samuel Refetoff and Fein, {Henry G.} and Weintraub, {Bruce D.}",
year = "1991",
month = "10",
day = "16",
doi = "10.1001/jama.1991.03470150090036",
language = "English (US)",
volume = "266",
pages = "2118--2120",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "15",

}

TY - JOUR

T1 - Pseudomalabsorption of Levothyroxine

AU - Ain, Kenneth B.

AU - Refetoff, Samuel

AU - Fein, Henry G.

AU - Weintraub, Bruce D.

PY - 1991/10/16

Y1 - 1991/10/16

N2 - Objective.—The issue of patient compliance with pharmacological therapy vs malabsorption of medication was explored in the context of persistent hypothyroidism despite the administration of large doses of levothyroxine sodium. Design.—Retrospective case series. Setting.—Referred care in two large tertiary care centers. Patients.—Four patients, seen within two decades, with clinical and biochemical hypothyroidism while receiving levothyroxine, were evaluated for selective malabsorption of this hormone. Interventions.—Studies included serial measurements of thyroid hormone levels after a loading dose of levothyroxine or liothyronine sodium or evaluation with a double-labeled thyroxine tracer technique. Results were compared with studies of levothyroxine malabsorption in the medical literature. Results.—All patients were ultimately found to have normal (82% to 100%) absorption of oral levothyroxine. There was no evidence that malabsorption of levothyroxine can occur as an isolated abnormality. Conclusions.—Some patients exhibit a factitious disorder suggesting malabsorption of levothyroxine. When treating hypothyroidism, psychiatric issues may result in noncompliance with levothyroxine therapy.

AB - Objective.—The issue of patient compliance with pharmacological therapy vs malabsorption of medication was explored in the context of persistent hypothyroidism despite the administration of large doses of levothyroxine sodium. Design.—Retrospective case series. Setting.—Referred care in two large tertiary care centers. Patients.—Four patients, seen within two decades, with clinical and biochemical hypothyroidism while receiving levothyroxine, were evaluated for selective malabsorption of this hormone. Interventions.—Studies included serial measurements of thyroid hormone levels after a loading dose of levothyroxine or liothyronine sodium or evaluation with a double-labeled thyroxine tracer technique. Results were compared with studies of levothyroxine malabsorption in the medical literature. Results.—All patients were ultimately found to have normal (82% to 100%) absorption of oral levothyroxine. There was no evidence that malabsorption of levothyroxine can occur as an isolated abnormality. Conclusions.—Some patients exhibit a factitious disorder suggesting malabsorption of levothyroxine. When treating hypothyroidism, psychiatric issues may result in noncompliance with levothyroxine therapy.

UR - http://www.scopus.com/inward/record.url?scp=0025934765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025934765&partnerID=8YFLogxK

U2 - 10.1001/jama.1991.03470150090036

DO - 10.1001/jama.1991.03470150090036

M3 - Article

C2 - 1920700

AN - SCOPUS:0025934765

VL - 266

SP - 2118

EP - 2120

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 15

ER -